News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
127,664 Results
Type
Article (4279)
Company Profile (93)
Press Release (123292)
Section
Business (42075)
Career Advice (207)
Deals (6158)
Drug Delivery (13)
Drug Development (17442)
Employer Resources (18)
FDA (1487)
Job Trends (2777)
News (66224)
Policy (3646)
Tag
Academia (288)
Alliances (11419)
Alzheimer's disease (291)
Approvals (1484)
Artificial intelligence (27)
Bankruptcy (38)
Best Places to Work (2236)
Biotechnology (89)
Breast cancer (52)
Cancer (379)
Career advice (195)
CAR-T (38)
Cell therapy (122)
Clinical research (13846)
Collaboration (181)
Compensation (63)
COVID-19 (422)
C-suite (61)
Cystic fibrosis (22)
Data (410)
Diabetes (34)
Diagnostics (673)
Drug discovery (34)
Earnings (12195)
Events (24188)
Executive appointments (182)
FDA (1628)
Funding (151)
Gene therapy (53)
GLP-1 (99)
Government (339)
Healthcare (1511)
Infectious disease (443)
Inflammatory bowel disease (43)
Intellectual property (21)
IPO (2911)
Job creations (667)
Job search strategy (184)
Layoffs (35)
Legal (635)
Lung cancer (23)
Lymphoma (33)
Manufacturing (60)
Medical device (395)
Medtech (395)
Mergers & acquisitions (3376)
Metabolic disorders (83)
Neuroscience (377)
NextGen: Class of 2025 (856)
Non-profit (271)
Northern California (583)
Obesity (45)
Opinion (37)
Parkinson's disease (28)
Patents (31)
People (16210)
Phase I (5505)
Phase II (6599)
Phase III (3388)
Pipeline (176)
Policy (22)
Postmarket research (209)
Preclinical (2355)
Press Release (51)
Radiopharmaceuticals (44)
Rare diseases (52)
Real estate (1440)
Regulatory (2885)
Research institute (299)
Series A (26)
Southern California (527)
Startups (983)
United States (4499)
Vaccines (58)
Date
Today (9)
Last 7 days (90)
Last 30 days (493)
Last 365 days (9075)
2025 (439)
2024 (9152)
2023 (9887)
2022 (12001)
2021 (12651)
2020 (9855)
2019 (6682)
2018 (5281)
2017 (6081)
2016 (5593)
2015 (6446)
2014 (4927)
2013 (4070)
2012 (4424)
2011 (4877)
2010 (4520)
Location
Africa (137)
Alabama (24)
Asia (8391)
Australia (1970)
California (1321)
Canada (434)
China (82)
Connecticut (51)
Europe (18182)
Florida (116)
Illinois (104)
Indiana (74)
Maryland (159)
Massachusetts (971)
Michigan (59)
Minnesota (78)
New Jersey (308)
New York (317)
North Carolina (203)
Northern California (583)
Ohio (29)
Pennsylvania (285)
South America (199)
Southern California (527)
Texas (148)
Washington State (262)
127,664 Results for "puma biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation
December 23, 2024
·
8 min read
Press Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - January 3, 2025
January 6, 2025
·
2 min read
Press Releases
Puma Biotechnology Reports Third Quarter 2024 Financial Results
November 7, 2024
·
17 min read
Biotech Beach
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - June 07, 2024
Puma Biotechnology, Inc., a biopharmaceutical company, announced that on June 6, 2024, the Compensation Committee of Puma’s Board of Directors approved the grant of an inducement restricted stock unit award covering 3,500 shares of Puma common stock to one new non-executive employee.
June 7, 2024
·
2 min read
Business
Puma Biotechnology Reports First Quarter 2024 Financial Results
Puma Biotechnology, Inc., a biopharmaceutical company, announced financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
15 min read
Biotech Beach
Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the release of abstracts on alisertib to be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
May 23, 2024
·
2 min read
Press Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - December 4, 2024
December 5, 2024
·
2 min read
Business
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
October 24, 2024
·
2 min read
Biotech Beach
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - April 03, 2024
Puma Biotechnology, Inc., a biopharmaceutical company, announced that on April 2, 2024, the Compensation Committee of Puma’s Board of Directors approved the grant of an inducement restricted stock unit award covering 7,500 shares of Puma common stock to one new non-executive employee.
April 3, 2024
·
2 min read
Press Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - November 5, 2024
November 6, 2024
·
2 min read
1 of 12,767
Next
